These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6117612

  • 1. Acute and subchronic effects of bometolol on blood pressure in hypertensive rats.
    Watanabe TX, Watanabe Y, Hasegawa Y, Kudo Y, Kawashima K, Sokabe H.
    J Pharmacobiodyn; 1981 Jul; 4(7):505-12. PubMed ID: 6117612
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antihypertensive activity of bucumolol, a beta-adrenergic blocking agent, in spontaneously hypertensive rats.
    Miyamoto M, Koike H, Ito K, Nishino H.
    J Pharmacobiodyn; 1981 Jul; 4(7):455-60. PubMed ID: 6117610
    [Abstract] [Full Text] [Related]

  • 6. Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects.
    Tanaka M, Masumura H, Tanaka S, Akashi A.
    J Cardiovasc Pharmacol; 1987 Jul; 10 Suppl 11():S52-7. PubMed ID: 2454368
    [Abstract] [Full Text] [Related]

  • 7. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
    Weiss L, Lundgren Y, Folkow B.
    Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
    [No Abstract] [Full Text] [Related]

  • 8. Effects of early carvedilol treatment and withdrawal on the development of hypertension and renal vascular narrowing.
    Kett MM, Denton KM, Boesen EI, Anderson WP.
    Am J Hypertens; 2004 Feb; 17(2):161-6. PubMed ID: 14751659
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chronic effects of a beta-adrenoceptor blocking drug, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696), in hypertensive rats.
    Kubota N, Kishi K, Sokabe H, Kawashima K, Ishii Y, Kawase S.
    J Pharmacobiodyn; 1985 Feb; 8(2):134-41. PubMed ID: 2861268
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.
    Hansson L, Aberg H, Jameson S, Karlberg B, Malmcrona R.
    Acta Med Scand; 1973 Dec; 194(6):549-50. PubMed ID: 4149321
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chronic effects of arotinolol (S-596) in spontaneously hypertensive rats.
    Kishi K, Kawashima K, Sokabe H, Saito K.
    J Pharmacobiodyn; 1985 Jan; 8(1):50-5. PubMed ID: 2409263
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of prolonged administration of indenolol in hypertensive rats.
    Kato H, Kurihara J, Takata Y, Kunugi H, Miyajima Y.
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):82-95. PubMed ID: 6138007
    [Abstract] [Full Text] [Related]

  • 19. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension.
    Sventek P, Turgeon A, García R, Schiffrin EL.
    J Hypertens; 1996 Jan; 14(1):57-64. PubMed ID: 12013496
    [Abstract] [Full Text] [Related]

  • 20. Effects of beta-adrenergic blocking drugs in hypertensive rats.
    Sukamoto T, Shiono K, Watanabe TX, Sokabe H.
    J Pharmacobiodyn; 1980 Jan; 3(1):1-10. PubMed ID: 6110712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.